Ruijin Hospital: all 667 studies

Page 3 of 7. Open to participants first (376), then studies with results posted, then the rest; newest registration first within each.

• Effect of Belimumab on Antibody Titers in Primary APS PatientsRecruitingNCT06747312Phase 2
• The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical StudyNot yet recruitingNCT06747299
• A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune DiseasesRecruitingNCT06747156Early Phase 1
• The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor TherapyRecruitingNCT06746194
• The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node MetastasesRecruitingNCT06730529
• Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1RecruitingNCT06718244Phase 2
• A Fast, Quiet, Artificial Intelligence-based PET/MR Solution for Paediatric DiseasesRecruitingNCT06709690
• Allogeneic Hematopoietic Stem Cell Transplantation Cohort StudyRecruitingNCT06708130
• Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell TransplantationNot yet recruitingNCT06704542
• CR-CHOP+X in Previously Untreated DELRecruitingNCT06701357Phase 2
• Go-CHOP in de Novo Intestinal T-cell Lymphoma PatientsNot yet recruitingNCT06701344Phase 2
• The Effect of Physical Activity Level Evaluated by Wrist-wearable Devices on Cardiovascular Disease Risk and Other Outcomes in Peritoneal Dialysis PatientsEnrolling by invitationNCT06697418
• Liposomal Irinotecan Combined with Sintilimab for Second-line Treatment of Progressive Gastric CancerNot yet recruitingNCT06697366Phase 2
• Immunobridging/Maintenance Therapy Versus Non-bridging Therapy in CAR-T Therapy for Low-risk R/R B-NHLRecruitingNCT06695013Phase 2
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by VirusesRecruitingNCT06693362Phase 1
• Irreversible Electroporation Ablation Combined With Anti-PD(L)1 Therapy for Locally Advanced Pancreatic CancerNot yet recruitingNCT06677762
• Zanubrutinib-based Maintenance Therapy of Newly Diagnosed DLBCL With Initial RemissionNot yet recruitingNCT06669143Phase 2
• Efficacy and Safety Research of Cold Snare Polypectomy and Hot Snare Polypectomy in the Treatment of 4-9 mm Diameter Colorectal 0-Isp and 0-Ip Polyps: a Prospective, Multicenter, Randomized Controlled Study(FAST -REST Study)Not yet recruitingNCT06658561Not applicable
• The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter StudyNot yet recruitingNCT06656234
• A Prospective, Single-Center Study Evaluating the Efficacy and Safety of Glofitamab Combined With Orelabrutinib and Bortezomib in Patients With High-Risk Mantle Cell LymphomaNot yet recruitingNCT06656221Phase 2
• Efficacy and Safety of Telitacicept in IgANRecruitingNCT06654596Not applicable
• Molecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid LeukemiaNot yet recruitingNCT06652685Phase 2
• Zanubrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCLNot yet recruitingNCT06652165Phase 2
• Mechanism Investigation of R-CHOP Regimen or Tucidinostat Plus R-CHOP (CR-CHOP) Regimen in the Treatment of BCL2/MYC Protein Double Expressor LymphomaNot yet recruitingNCT06652152
• Selinexor Combined With BEAM for ASCT in R/R DLBCL With MYC PositiveNot yet recruitingNCT06652139Phase 2
• ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCTNot yet recruitingNCT06646666Phase 2
• The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Soft Tissue SarcomasRecruitingNCT06644287
• The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Gastrointestinal MalignanciesRecruitingNCT06644274
• Respiratory Virome Diversity and Baseline Immunity in Healthy Individuals in ShanghaiRecruitingNCT06641856
• Quantitative Ultrasound Assessment of Abdominal Cavity SpaceNot yet recruitingNCT06634732
• The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung CancerRecruitingNCT06623487
• 68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.RecruitingNCT06608160
• The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)RecruitingNCT06601075
• The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.RecruitingNCT06601010
• The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Hepatobiliary MalignancyRecruitingNCT06597539
• The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.RecruitingNCT06597526
• Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell CarcinomaRecruitingNCT06596954Not applicable
• Autologous Hematopoietic Stem Cell Boost Study After CAR-T TherapyRecruitingNCT06589089Phase 2
• HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic CancerRecruitingNCT06587061Phase 2
• Current Situation of Health Care in Women With HBV or HCV InfectionNot yet recruitingNCT06579313
• Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid TumorsRecruitingNCT06577532Early Phase 1
• Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPCNot yet recruitingNCT06573398Phase 2
• Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCLNot yet recruitingNCT06573151Phase 2
• Selinexor, Anti-PD-1 Antibody Plus Golidocitinib in R/R NKTCLNot yet recruitingNCT06573138Phase 2
• A Real-World Study on Extranodal LymphomaNot yet recruitingNCT06573099
• De-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCCRecruitingNCT06572514Phase 1/2
• CAR T-cell Therapy in Combination With Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma With High-Risk Prognostic FactorsNot yet recruitingNCT06567366Phase 2
• A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver MetastasesRecruitingNCT06567353Not applicable
• Antithrombotic Therapy With Regulation of Blood Pressure in Non-Cardioembolic Progressive StrokeEnrolling by invitationNCT06551727Not applicable
• Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL)Not yet recruitingNCT06549335Phase 2
• A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive JaundiceRecruitingNCT06541340Not applicable
• Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data CollectionRecruitingNCT06541327
• Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative DementiaRecruitingNCT06534658
• Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction TreatmentRecruitingNCT06534489
• Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE)RecruitingNCT06534463
• Study on Postoperative Adrenal Function Assessment in Patients With Primary AldosteronismNot yet recruitingNCT06534268
• The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell LymphomaRecruitingNCT06522555Phase 3
• Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal MetastasisRecruitingNCT06519591Phase 2
• Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic CancerRecruitingNCT06496373Early Phase 1
• Bendamustine and Rituximab With or Without Orelabrutinib in MCL TreatmentRecruitingNCT06496308Phase 3
• A Study of LCAR-HL30 in Subjects With Relapsed/Refractory Hodgkin's Lymphoma and Anaplastic Large Cell LymphomaRecruitingNCT06494371Phase 1
• Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy (Adebrelimab) Combined With Chemotherapy (XELOX): a Prospective, Single-center, Feasibility StudyRecruitingNCT06482788Phase 2
• A Trial on the Remission Rates of Type I Autoimmune Pancreatits With High-risk of RecurrenceRecruitingNCT06468709Phase 4
• The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid LeukemiaRecruitingNCT06458257
• The Efficacy of Allo-HSCT in ND HR-CBF-AMLRecruitingNCT06458244
• Efficacy of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCLNot yet recruitingNCT06441097Phase 2
• Blinatumomab Maintenance After Allo-HSCTNot yet recruitingNCT06438796Phase 2
• Effect of Oxycodone on Anxiety State in Painless AbortionNot yet recruitingNCT06435949Early Phase 1
• Boost Irradiation to the Supraclavicular Area Among High Risk cN3c Breast Cancer PatientsRecruitingNCT06404697Phase 2
• Analysis of Deep Brain Nuclei LFP and Cortical EEG Signals During the Recovery From General AnesthesiaRecruitingNCT06400901
• a Ultrasonographic Measurement of Intra-abdominal PressureNot yet recruitingNCT06390605
• Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon CancerRecruitingNCT06368141Phase 2
• CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic FactorsRecruitingNCT06365671Phase 2
• An Evaluation of LY007 Cell Injection for r/r B-NHLRecruitingNCT06364852Phase 1
• An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).RecruitingNCT06339060Phase 3
• A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AMLRecruitingNCT06329999Not applicable
• Cognitive Impairment Cohort Study of the Elderly Population in YuGardenNot yet recruitingNCT06325527
• Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MRNot yet recruitingNCT06297772Phase 3
• Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive ExpressionRecruitingNCT06269211Phase 2
• Toripalimab Combined With Definitive CCRT for LACC PatientsRecruitingNCT06256224Not applicable
• The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell LymphomaNot yet recruitingNCT06255795Phase 3
• Evaluate the Efficacy and Safety of Allogeneic Haematopoietic Stem Cell Transplantation With FBM Conditioning for MDSRecruitingNCT06247917Phase 2
• In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine TumorRecruitingNCT06246630Not applicable
• Valuate the Clinical Performance and Safety of da Vinci SP Surgical SystemRecruitingNCT06246617Not applicable
• a Feasibility Study of iHD-SRT for BMRecruitingNCT06231186Not applicable
• A Study on the Prophylactic Use of Antibiotics Within 72 Hours After Acute Burn Injury in PatientsNot yet recruitingNCT06221761Not applicable
• Individual Neuromodulation for PDSRecruitingNCT06193278Not applicable
• A Real-World Study to Evaluate the Clinical Performance and Safety of da Vinci SP Surgical System for Single-Port Urological SurgeriesRecruitingNCT06181942
• Clinical Research on Shenfu Injection in Septic PatientsRecruitingNCT06157320Not applicable
• Famitinib in Combination With Adebrelimab for the Treatment of Advanced Thyroid CancerNot yet recruitingNCT06146985Phase 2
• Risk Factors and Outcomes in Coronary Chronic Total OcclusionRecruitingNCT06137521
• A Study of the Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell LymphomaRecruitingNCT06136351Phase 2
• Organ Protective Effect of Cetirizine In Patients With Severe BurnsRecruitingNCT06126991Phase 1/2
• Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell CarcinomaRecruitingNCT06122493Phase 2
• The Effect of PERT on Patients Undergoing PancreaticoduodenectomyRecruitingNCT06119880Phase 4
• Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical TrialRecruitingNCT06114225Phase 2
• A Clinical Validation Study to Evaluate the Diagnostic Accuracy of a Cough-based Auxiliary Diagnosis Algorithm for COPDRecruitingNCT06082791
• A Real-World Study to Evaluate the Clinical Performance and Safety of da Vinci SP Surgical System for Single-Port Gynecological Surgeries(SPiM-RWS-GYN)RecruitingNCT06082011
• Remote Programming for Deep Brain Stimulation in Parkinson's Disease.RecruitingNCT06078397Not applicable
• PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)RecruitingNCT06074692Phase 2

← Ruijin Hospital overview and focus areas